Immuneering Ownership | Who Owns Immuneering?
Immuneering Ownership Summary
Immuneering is owned by 78.38% institutional investors, 13.82% insiders, and 7.80% retail investors. Fmr is the largest institutional shareholder, holding 14.21% of IMRX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.22% of its assets in Immuneering shares.
IMRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immuneering | 78.38% | 13.82% | 7.80% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 9.19M | 14.21% | $37.65M |
| Blackrock funding, inc. /de | 4.87M | 7.53% | $19.95M |
| Vanguard group | 2.57M | 6.47% | $16.90M |
| Price t rowe associates inc /md/ | 1.94M | 4.40% | $9.66M |
| Exoduspoint capital management, lp | 1.52M | 4.22% | $10.62M |
| Sanofi | 2.71M | 4.19% | $11.09M |
| Vanguard capital management | 2.28M | 3.53% | $9.36M |
| Logos global management lp | 950.00K | 2.64% | $6.65M |
| Geode capital management | 1.37M | 2.12% | $5.63M |
| Blackrock | 533.36K | 1.82% | $682.71K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Southport management | 272.50K | 7.87% | $1.91M |
| Sanofi | 2.71M | 1.76% | $11.09M |
| Alethea capital management | 472.94K | 0.99% | $1.94M |
| Dcf advisers | 862.50K | 0.80% | $3.53M |
| Occam crest management lp | 324.70K | 0.71% | $1.33M |
| Logos global management lp | 950.00K | 0.60% | $6.65M |
| Pvg asset management | 146.45K | 0.42% | $730.79K |
| Flower city capital | 55.03K | 0.12% | $274.60K |
| Prosight management, lp | 150.00K | 0.12% | $614.25K |
| Exoduspoint capital management, lp | 1.52M | 0.11% | $10.62M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Exoduspoint capital management, lp | 1.52M | 0.11% | 1.52M |
| Logos global management lp | 950.00K | 0.60% | 950.00K |
| Abrdn | 784.95K | 0.00% | 784.95K |
| Blackrock funding, inc. /de | 4.87M | 0.00% | 497.41K |
| Nuveen | 869.39K | 0.00% | 431.03K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cormorant asset management, lp | - | - | -3.30M |
| Empery asset management, lp | - | - | -2.67M |
| Blackrock | 533.36K | - | -843.76K |
| Millennium management | 330.40K | 0.00% | -772.31K |
| Blue owl capital lp | - | - | -665.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Exoduspoint capital management, lp | 1.52M | 0.11% | 1.52M | $10.62M |
| Logos global management lp | 950.00K | 0.60% | 950.00K | $6.65M |
| Abrdn | 784.95K | 0.00% | 784.95K | $3.21M |
| Gendell jeffrey l | 387.77K | 0.02% | 387.77K | $1.59M |
| Two sigma advisers, lp | 248.70K | 0.00% | 248.70K | $318.34K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Nisa investment advisors | -10.00 |
| Point72 (difc) | -16.00 |
| Jones financial companies lllp | -30.00 |
| Sbi securities | -74.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 117 | 15.84% | 34,496,071 | 17.71% | 78 | 1.77% | 73 | 23.73% | 21 | 5.00% |
| Mar 31, 2026 | 51 | -45.16% | 6,458,494 | -79.66% | 14 | 0.23% | 31 | -47.46% | 8 | -33.33% |
| Dec 31, 2025 | 64 | -7.25% | 18,176,982 | -30.34% | 45 | 0.87% | 43 | -24.56% | 9 | 28.57% |
| Sep 30, 2025 | 68 | 74.36% | 26,041,962 | 580.01% | 72 | 62.29% | 56 | 194.74% | 7 | 16.67% |
| Jun 30, 2025 | 39 | 14.71% | 3,829,641 | -14.87% | 10 | 6.72% | 19 | 46.15% | 6 | -33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 4.02M | 6.22% | - |
| HBM Healthcare Investments AG Ord | 3.65M | 5.63% | - |
| Fidelity Growth Company Fund | 2.94M | 4.54% | - |
| State Street® SPDR® S&P® Biotech ETF | 2.18M | 3.37% | 12.07K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.62M | 2.51% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.62M | 2.51% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.62M | 2.51% | - |
| iShares Russell 2000 ETF | 1.38M | 2.14% | - |
| Fidelity Select Biotechnology | 1.10M | 1.69% | - |
| US Small-Cap Growth II Equity Comp | 906.76K | 1.40% | 215.29K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Zeskind Benjamin J. | PRESIDENT AND CEO | Buy | $10.95K |
| Jun 15, 2026 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | $25.05K |
| Jan 16, 2026 | Brakewood Harold Eugene | Chief Business Officer | Buy | $24.99K |
| Jan 15, 2026 | Schall Thomas J. | - | Buy | $101.04K |
| Jan 15, 2026 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | $10.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | - |
| 2026 Q3 | - | - |
| 2026 Q2 | 2 | - |
| 2026 Q1 | 5 | - |
| 2025 Q4 | 4 | - |
IMRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools